Bupivacaine is also known by the brand name Marcaine [1].
What is Bupivacaine used for?
Bupivacaine is a local anesthetic used to block nerve impulses and numb an area of the body. It is administered for surgical anesthesia, obstetrical anesthesia, and for short-term pain relief after surgery [1].
How does Bupivacaine work?
As a local anesthetic, bupivacaine works by reversibly blocking nerve conduction. It achieves this by inhibiting the influx of sodium ions into the nerve cell membrane, which prevents the generation and conduction of nerve impulses [1].
What is the difference between Bupivacaine and Lidocaine?
Both bupivacaine and lidocaine are local anesthetics, but they differ in their duration of action. Bupivacaine has a longer duration of action compared to lidocaine, making it suitable for procedures requiring prolonged pain relief [1].
What are the common side effects of Bupivacaine?
Common side effects of bupivacaine include nausea, vomiting, dizziness, headache, and chills. More serious side effects can occur, such as changes in heart rate and rhythm, and central nervous system effects like drowsiness or seizures [1].
When does Bupivacaine patent exclusivity expire?
Information regarding specific patent expiry dates for bupivacaine can be found on DrugPatentWatch.com. Generally, bupivacaine is an older drug, and its primary patents have long since expired, leading to the availability of generic versions [2].
Who manufactures Bupivacaine?
Bupivacaine is manufactured and marketed by several pharmaceutical companies under various brand names, including Marcaine, which is associated with Fresenius Kabi [1]. Generic versions are also widely available.